(Press-News.org) New clinical strains of cholera appear to have evolved a distinctly different mechanism to cause the same disease according to research published in the current issue of the online journal mBio®.
Vibrio cholerae is the causative agent for the diarrheal disease cholera. While there are more than 200 different serogroups only the O1 and the O139 strains have been known to cause epidemic and pandemic outbreaks of disease, using a toxin-coregulated pilus (TCP) and cholera toxin (CT), which other strains lack.
"While non-O1, non-O139 strains have caused sporadic disease globally, the virulence mechanisms are not fully understood, since most of these strains lack TCP and CT," say the researchers from Harvard Medical School and the International Center for Diarrhoeal Research in Dhaka, Bangladesh.
The researchers studied a newly identified non-O1, non-O139 strain of the bacteria called AM-19226. Using comparative genomics, they investigated how this new strain causes diarrhea.
Many pathogenic bacteria require something called a type III secretion system (T3SS) in order to cause disease. In previous studies, the researchers discovered a T3SS and identified a protein (vopF) that they believe could be involved in causing disease.
In the current study they identified an additional protein (vopE) and using mouse models show that AM-19226 requires T3SS to cause diarrhea and that both vopE and vopF contribute to the disease.
"With the discovery of the T3SS in V. cholerae and its role in the virulence of non-O1 and non-O139 strains, it is astonishing to observe how this bacterium has evolved two independent pathogenic mechanisms to cause similar disease," say the researchers.
###
mBio® is a new open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.
Cholera strain evolves new mechanism for causing disease
2010-12-10
ELSE PRESS RELEASES FROM THIS DATE:
Lighter bikes may not reduce commuting time
2010-12-10
A light-weight bike that costs around £1000 may not get you to work any quicker than a similar, yet heavier and cheaper model, finds research in the Christmas issue published on bmj.com today.
A keen cyclist since childhood, the author Dr Jeremy Groves, owns two bikes. One a second hand 13.5 kg steel framed bike bought for £50 and the other a brand new 9.5 kg carbon framed bike that cost £1000.
When Dr Groves, a consultant in anaesthesia and intensive care at Chesterfield Royal Hospital, realised his new bike took 43 minutes to get him to work rather than the 44 minutes ...
Doctors don't need to fear red heads
2010-12-10
A study in the BMJ's Christmas issue published on bmj.com today confirms that there is no need for doctors to fear red heads.
The research concludes that, contrary to popular belief, people with red hair do not bleed any more than other patients.
The authors, led by surgeon Jonathan Barry from Morriston Hospital in Swansea, say that "red haired patients are traditionally regarded with a degree of trepidation by surgeons and anaesthetists alike due to a reputation for excessive bleeding, reduced pain threshold and a propensity to develop hernias".
Globally around 1-2% ...
Powdery mildew at an evolutionary dead end
2010-12-10
The size of a genome tells us nothing about the comprehensiveness of the genetic information it contains. The genome of powdery mildew, which can destroy entire harvests with its fine fungal threads, is a good example of this. Although the pathogen has almost 120 million base pairs, and therefore one of the largest genomes of the sac fungi, at barely 6,000, its gene count is far lower than that of comparable species. It has lost many of the genes required for separate metabolism found in other fungi. Thus, from a genetic perspective, powdery mildew is stuck in an evolutionary ...
Computer-based program may help relieve some ADHD symptoms in children
2010-12-10
COLUMBUS, Ohio – An intensive, five-week working memory training program shows promise in relieving some of the symptoms of attention deficit hyperactivity disorder in children, a new study suggests.
Researchers found significant changes for students who completed the program in areas such as attention, ADHD symptoms, planning and organization, initiating tasks, and working memory.
"This program really seemed to make a difference for many of the children with ADHD," said Steven Beck, co-author of the study an associate professor of psychology at Ohio State University.
"It ...
Living in certain neighborhoods increases the chances older men and women will develop cancer
2010-12-10
ANN ARBOR, Mich.---Older people who live in racially segregated neighborhoods with high crime rates have a much higher chance of developing cancer than do older people with similar health histories and income levels who live in safer, less segregated neighborhoods.
That is one of the key findings of a new study forthcoming in the January 2011 issue of the American Journal of Public Health. The study was conducted by Vicki Freedman, an epidemiologist at the University of Michigan Institute for Social Research and colleagues at the University of Medicine and Dentistry of ...
When their tools get dull, leaf-cutters switch jobs
2010-12-10
EUGENE, Ore. -- (Dec. 9, 2010) -- When their razor-sharp mandibles wear out, leaf-cutter ants change jobs, remaining productive while letting their more efficient sisters take over cutting, say researchers from two Oregon universities.
Their study -- appearing online ahead of regular publication in the journal Behavioral Ecology and Sociobiology -- provides a glimpse of nature's way of providing for its displaced workers.
"This study demonstrates an advantage of social living that we are familiar with -- humans that can no longer do certain tasks can still make very ...
Buprenorphine treatment produces improved outcome for babies born addicted
2010-12-10
Babies born into the world addicted to drugs because of their mother's dependence on pain medication, or opioids, may be weaned off the substance more comfortably, with a shorter hospital stay and at a reduced cost, if the mother receives a new treatment option during pregnancy.
A New England Journal of Medicine study published Dec. 9, co-authored by Vanderbilt's Peter Martin, M.D., director of the Division of Addiction Psychiatry, found that the newer buprenorphine is at least as good for both mother and child as the standard care methadone, when both were combined with ...
Unraveling Alzheimer's: Simple small molecules could untangle complex disease
2010-12-10
ANN ARBOR, Mich.---New molecular tools developed at the University of Michigan show promise for "cleansing" the brain of amyloid plaques, implicated in Alzheimer's disease.
A hallmark of Alzheimer's disease---a neurodegenerative disease with no cure---is the aggregation of protein-like bits known as amyloid-beta peptides into clumps in the brain called plaques. These plaques and their intermediate messes can cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
The mechanisms responsible for the formation of these ...
2 decades of Nuss procedure outcomes: Refinements in groundbreaking surgery for chest deformity
2010-12-10
Since 1987, when a surgeon at Children's Hospital of The King's Daughters developed a minimally-invasive surgery to correct sunken chest, the procedure has been adopted world-wide as a standard of care and continually refined to increase its effectiveness and safety, according to a paper published in the December issue of the Annals of Surgery.
Coming more than two decades after the procedure was developed by surgeon Donald Nuss, the article summarizes the cases of 1,215 patients who had the Nuss Procedure at Children's Hospital of The King's Daughters and focuses on ...
Patients may not have to stop taking anti-platelets for some surgeries
2010-12-10
Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary. The study will be published in the December issue of the Annals of Vascular Surgery.
The use of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis), an antiplatelet agent prescribed for patients with acute myocardial infarction (severe heart attack), recent stroke or peripheral arterial disease, continues to rise with U.S. sales ...